June 15, 2019
The Healthcare Distribution Alliance (HDA) issued the following statement in response to the Rhode Island Legislature’s inclusion of a $5 million fee on prescription opioids in the state budget.
Healthcare Distribution Alliance – Patients Move Us.
SEARCH
News
FEATURED NEWS
HDA Statement on Inspector General's DEA Report
October 1, 2019
In response to the release of the U.S. Department of Justice Office of the Inspector General's Review of the Drug Enforcement Administration’s (DEA) Regulatory and Enforcement Efforts to Control the Diversion...
HDA Statement on HHS-FDA "Safe Importation Action Plan"
July 31, 2019
The Healthcare Distribution Alliance (HDA) released the following statement on the release of the “Safe Importation Action Plan” by the Department of Health and Human Services (HHS) and U.S. Food and Drug...
New Analysis Notes the Critical and Evolving Role Pharmaceutical Distributors Play in U.S. Healthcare
July 30, 2019
A new report published by the Healthcare Distribution Alliance (HDA) and Deloitte Consulting LLP highlights the value distributors provide to the United States healthcare ecosystem and estimates pharmaceutical...
Analysis: Importation Policies Cost-Prohibitive to U.S. Healthcare System, Pose Risks to Patients
July 15, 2019
A new report published by the HDA Research Foundation concludes that federal proposals to permit the importation of prescription drugs into the U.S. fail to provide comprehensive guidance and funding to...
-
HDA Statement on Rhode Island Opioid Fee
-
HDA Honors Manufacturers With 2019 DIANA AwardsJune 4, 2019
The Healthcare Distribution Alliance (HDA) honored pharmaceutical and consumer product manufacturers with the annual Distribution Industry Awards for Notable Achievements in Healthcare (DIANA). The honorees were formally recognized during the DIANA and Nexus Awards dinner at the HDA 2019 Business and Leadership Conference in Orlando, Fla.
-
HDA Supports PAHPA ReauthorizationJune 4, 2019
Following the passage of legislation to reauthorize the Pandemic and All-Hazards Preparedness and Advancing Innovation Act, Healthcare Distribution Alliance (HDA) President and CEO John M. Gray released this statement.
-
John M. Gray Announces Retirement From HDAJune 3, 2019
John M. Gray, President and CEO of the Healthcare Distribution Alliance (HDA), today announced his retirement from the organization. Mr. Gray will remain in his position until May 2, 2020.
-
Novartis and Sandoz Honored with Power of Partnership AwardJune 3, 2019
Americares, in partnership with the Healthcare Distribution Alliance (HDA), has presented its annual Power of Partnership Award to Novartis and its Sandoz division, in recognition of their outstanding commitment to increasing access to health care around the world.
Media Contacts
John Parker
(703) 885-0216
Farah Simonett
(703) 885-0269
